Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SED80 for inflammation and pain after cataract surgery
NCT04711213Phase 2Completed
- Sponsor
- iDrop Inc
- Start
- Sep 2020
- Primary completion
- Oct 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in ocular inflammation, sponsored by iDrop Inc. Started Sep 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT04711213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04711213.